Laxman Yetukuri

Åbo Akademi University — Finland

Biochemistry, Genetics and Molecular Biology · Life Sciences

28h-index5.6kcitations90works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Metabolomics and Mass Spectrometry Studies(41), Cancer, Lipids, and Metabolism(28), Fatty Acid Research and Health(26), Ubiquitin and proteasome pathways(15), Liver Disease Diagnosis and Treatment(8)

Publications90 total

Machine Learning-Boosted Docking Enables the Efficient Structure-Based Virtual Screening of Giga-Scale Enumerated Chemical Libraries
Journal of Chemical Information and Modeling·2023· 33 citedOpen Access
Machine Learning-Boosted Docking Enables the Efficient Structure-Based Virtual Screening of Giga-Scale Enumerated Chemical Libraries
2023· 1 citedOpen Access
<scp>PP2A</scp> ‐based triple‐strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells
Molecular Oncology·2023· 8 citedOpen Access
Author response for "&lt;scp&gt;PP2A&lt;/scp&gt;‐based triple‐strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells"
2023
Supplementary table S3 from &lt;i&gt;UBR5&lt;/i&gt; Is Coamplified with &lt;i&gt;MYC&lt;/i&gt; in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
2023Open Access
Supplementary Figures 1-6 from &lt;i&gt;UBR5&lt;/i&gt; Is Coamplified with &lt;i&gt;MYC&lt;/i&gt; in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
2023Open Access
Supplementary table S2 from &lt;i&gt;UBR5&lt;/i&gt; Is Coamplified with &lt;i&gt;MYC&lt;/i&gt; in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
2023Open Access
Supplementary table S1 from &lt;i&gt;UBR5&lt;/i&gt; Is Coamplified with &lt;i&gt;MYC&lt;/i&gt; in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
2023Open Access
Supplementary Figures 1-6 from &lt;i&gt;UBR5&lt;/i&gt; Is Coamplified with &lt;i&gt;MYC&lt;/i&gt; in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
2023Open Access
Supplementary materials and methods from &lt;i&gt;UBR5&lt;/i&gt; Is Coamplified with &lt;i&gt;MYC&lt;/i&gt; in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
2023Open Access
Supplementary materials and methods from &lt;i&gt;UBR5&lt;/i&gt; Is Coamplified with &lt;i&gt;MYC&lt;/i&gt; in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
2023Open Access
Supplementary table S3 from &lt;i&gt;UBR5&lt;/i&gt; Is Coamplified with &lt;i&gt;MYC&lt;/i&gt; in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
2023Open Access
Supplementary table S1 from &lt;i&gt;UBR5&lt;/i&gt; Is Coamplified with &lt;i&gt;MYC&lt;/i&gt; in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
2023Open Access
Data from &lt;i&gt;UBR5&lt;/i&gt; Is Coamplified with &lt;i&gt;MYC&lt;/i&gt; in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
2023Open Access
Supplementary table S2 from &lt;i&gt;UBR5&lt;/i&gt; Is Coamplified with &lt;i&gt;MYC&lt;/i&gt; in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
2023Open Access
Data from &lt;i&gt;UBR5&lt;/i&gt; Is Coamplified with &lt;i&gt;MYC&lt;/i&gt; in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
2023Open Access
Supplementary Table 8 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 1 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 6 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 1 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Matej Orešič(31), Tuulikki Seppänen‐Laakso(15), Tero Aittokallio(14), Jukka Westermarck(11), Peddinti Gopalacharyulu(9), Tuulia Hyötyläinen(9), Krister Wennerberg(9), Vidya Velagapudi(8), Marko Sysi‐Aho(8), Joni Merisaari(8), Sandra Castillo(7), Heli Nygrén(7), Antonio Vidal‐Puig(7), Marja‐Riitta Taskinen(7), Mikael Jumppanen(7), Hannele Yki‐Järvinen(6), Jing Tang(6), Ilpo Vattulainen(6), Otto Kauko(6), Michael Ohlmeyer(6)